Skip to main content
Clinical Trials/NCT00982046
NCT00982046
Completed
Not Applicable

A Clinical Comparison of Three Contact Lens Care Systems and Their Effect on Contact Lenses

Alcon Research1 site in 1 country75 target enrollmentApril 2009
ConditionsContact Lenses

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Contact Lenses
Sponsor
Alcon Research
Enrollment
75
Locations
1
Primary Endpoint
End of day comfort
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study was to evaluate the clinical performance of three differing contact lens care solutions when used in conjunction with three contact lenses.

Detailed Description

This study was conducted as three separate studies based on the contact lens brand dispensed. In each study, the contact lens was evaluated in conjunction with three solutions: Opti-Free Replenish, ReNu MultiPlus, and Clear Care. The total enrollment number of 75 represents a combined enrollment of the three studies, with some subjects participating in more than one study.

Registry
clinicaltrials.gov
Start Date
April 2009
End Date
May 2010
Last Updated
9 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Signed informed consent.
  • Adapted contact lens wearer for at least one month.
  • Spherical prescription range between +6.00 to -8.00 diopters.
  • Astigmatism of less than or equal to 1.00 diopter in at least one eye.
  • Normal eyes with no evidence of abnormality or disease.
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria

  • Rigid Gas Permeable (RGP) contact lens wear in last 30 days.
  • Concurrent ocular medication, systemic illness, or medical treatment that will affect ocular physiology, lens performance, or vision.
  • Corneal infiltrates, scarring, or neovascularization within central 4 millimeters of cornea.
  • Eye injury or surgery within 8 weeks prior to study.
  • Aphakia, amblyopia, abnormal lacrimal secretions, ocular irritation, keratoconus, corneal irregularity, pregnancy, lactating, planning to become pregnant during the study, and participation in a concurrent clinical trial.
  • Other protocol-defined exclusion criteria may apply.

Outcomes

Primary Outcomes

End of day comfort

Time Frame: 2 weeks

As assessed by the subject as a measure of the comfort of the contact lenses at the end of an average day. End of day comfort is recorded on an 11-point scale where 0=poor and 10=excellent.

Bulbar hyperemia

Time Frame: 2 weeks

Bulbar hyperemia is the injection (or redness) of the blood vessels in the tissues overlaying the white of the eye. Bulbar hyperemia is measured on a 0-4 scale, with 0=none, 1=trace, 2=mild, 3=moderate, and 4=severe. Half-grades are allowed.

Corneal staining type

Time Frame: 2 weeks

An ophthalmic dye is used to highlight dead or degenerated corneal epithelial cells. The type of staining is measured over the five sectors of the cornea on a 0-4 scale, where 0=none, 1=micropunctate, 2=macropunctate, 3=coalesced macropunctate, and 4=patch (1mm). The five sectors are averaged to give a single score.

Upper palpebral roughness

Time Frame: 2 weeks

The roughness of the inner lining of the upper eyelid is measured on a 0-4 scale, where 0=uniform appearance, 1=trace, 2=mild, 3=moderate, and 4=severe. Half grades are allowed.

High contrast visual acuity

Time Frame: 2 weeks

High contrast visual acuity is a measure of the clearness of vision with full room illumination. Visual acuity is measured with a computer-generated, high contrast logMAR (logarithm minimum angle of resolution) chart.

Modulus

Time Frame: 2 weeks

Modulus is a measure of the stiffness of a contact lens material. Modulus is determined from the slope of the stress-strain curve created during tensile tests conducted on a sample of the material. Modulus is measured in mega Pascals (MPa). A higher modulus indicates a stiffer contact lens.

Study Sites (1)

Loading locations...

Similar Trials